Prognostic significance of impaired chronotropic response to pharmacologic stress Rb-82 PET
Naveen Bellam(Emory University), Leslee J. Shaw(Allegheny College), Brent A. Williams(Mayo Clinic), Benjamin J.W. Chow(Tufts Medical Center), Sharmila Dorbala(Brigham and Women's Hospital), Rob Beanlands(University of Ottawa), Michael E. Merhige, Arshed A. Quyyumi(Emory University), Marcelo F. Di Carli(Brigham and Women's Hospital), Daniel S. Berman(Cedars-Sinai Medical Center), Danny J. Eapen(Emory University), Emir Veledar(University of Miami), Sana Shah(Emory University), James K. Min(Cornell University)
Cited by 31
Related Papers
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease: Executive Summary
|Circulation|2012|2.4k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden
|Circulation|2008|1.6k
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease
|Journal of the American College of Cardiology|2012|1.6k